Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 07 December, 2018

JPMorgan Sec.Plc

Form 8.5 (EPT/RI)- Takeda Pharma Co Ltd AMEND

RNS Number : 8722J
JPMorgan Securities Plc
07 December 2018
 

AMENDMENT

INCREASED EQUITY PURCHASES BY 78,600 TO 383,614

INCREASED EQUITY SALES BY 44,000 TO 384,614

ADDED EQUITY SWAP PURCHASES OF 56,600

ADDED EQUITY SWAP SALES OF 104,400

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Takeda Pharmaceutical Company Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Joint Financial Adviser to Takeda Pharmaceutical Company Limited

(d) Date dealing undertaken:

05 December 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

     If it is a cash offer or possible cash offer, state "N/A"

Yes, Shire plc

 

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

(JPY)

Lowest price per unit paid/received

(JPY)

Ordinary Shares

 

Purchases

 

Sales

383,614

 

384,614

4,240.0000

 

4,240.0000

4,140.0000

 

4,140.0000

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(JPY)

 

 

Ordinary Shares

 

Equity Swaps

Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short

3,800

200

1,500

10,500

12,700

5,200

1,500

4,100

7,700

65,000

18,800

29,200

400

300

35,400

2,600

29,800

8,100

60,400

14,600

8,900

1,200

3,800

600

3,300

1,400

177,700

100

1,400

56,400

400

12,700

4,300

 

3,200

100

1,600

100

1,000

200

400

1,300

22,900

500

100

2,100

3,400

200

5,600

200

37,600

58,400

100

200

200

900

32,900

100

1,000

2,800

600

283,000

800

200

8,900

200

300

600

900

200

1,400

500

7,000

1,800

100

30,200

3,100

56,600

700

500

13,900

300

4,800

2,600

100

100

4,130.7221

4,139.0000

4,141.3333

4,142.3714

4,149.6680

4,164.5225

4,169.8000

4,179.4705

4,181.0006

4,186.4985

4,193.4415

4,193.4416

4,194.5805

4,194.6667

4,195.0000

4,197.2411

4,202.9463

4,210.6191

4,215.0474

4,215.4050

4,216.4535

4,222.2500

4,227.4038

4,229.4341

4,231.6312

4,231.8514

4,231.9842

4,236.0000

4,239.6429

4,240.0000

4,241.2500

4,278.5514

4,280.0065

 

4,126.0000

4,136.5000

4,148.0000

4,150.0000

4,150.7500

4,152.5000

4,156.2500

4,156.6923

4,157.0087

4,161.6600

4,168.0000

4,172.1905

4,185.8824

4,189.1000

4,192.1323

4,193.2500

4,193.4415

4,193.4416

4,197.0000

4,200.0500

4,200.2500

4,203.2312

4,203.5927

4,206.0000

4,206.4000

4,212.8929

4,213.5833

4,215.3863

4,215.7500

4,216.0270

4,216.6854

4,225.5000

4,229.1667

4,229.6667

4,230.6667

4,231.0500

4,231.8517

4,232.4800

4,234.1000

4,236.7500

4,238.1000

4,238.1921

4,239.8710

4,240.0000

4,243.7143

4,244.8600

4,250.8058

4,254.8333

4,257.7292

4,261.5385

4,282.0000

4,289.0000

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

(JPY)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(JPY)









 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 





 

 

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)


 

 



 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

07 December 2018

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FERUBOVRWBAURAA

a d v e r t i s e m e n t